| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9823 | 
      | Human Intestinal Absorption | HIA+ | 0.7379 | 
      | Caco-2 Permeability | Caco2- | 0.7273 | 
      | P-glycoprotein Substrate | Substrate | 0.5819 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9194 | 
                                                     | Non-inhibitor | 0.8007 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8794 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.3655 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8040 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8281 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5393 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.7490 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8202 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9005 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.7881 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.7951 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9449 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9903 | 
                                                                    | Non-inhibitor | 0.9180 | 
      | AMES Toxicity | Non AMES toxic | 0.7835 | 
      | Carcinogens | Non-carcinogens | 0.8563 | 
      | Fish Toxicity | High FHMT | 0.9169 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9406 | 
      | Honey Bee Toxicity | Low HBT | 0.6482 | 
      | Biodegradation | Not ready biodegradable | 0.9906 | 
      | Acute Oral Toxicity | IV | 0.5401 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5262 |